Silexion Therapeutics Corp (SLXN)

NCM – Real Time Price. Currency in USD

0.46

-0.57 (-55.55%)

Market open: Aug 12, 2026, 11:22 AM EDT

1.08

+0.04 (4.35%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-14K

-25K

-45K

Gross Profit

-14K

-25K

-45K

Operating expenses (excl. COGS)

-12M

-13M

-5M

-1M

Operating Income

-12M

-13M

-5M

-1M

Non-operating income, total

-277K

-4M

-395K

Pretax income

-12M

-17M

-5M

584K

Equity in earnings

Taxes

-3K

-10K

-32K

Non-controlling/minority interest

76K

166K

After tax other income/expense

Net income before discontinued operations

-12M

-16M

-5M

584K

Discontinued operations

Net income

-12M

-16M

-5M

584K

Dilution adjustment

Preferred dividends

Silexion Therapeutics Corp (SLXN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Silexion Therapeutics Corp (SLXN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Silexion Therapeutics Corp (SLXN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Silexion Therapeutics Corp (SLXN)

Income Statement (Annual)

Income Statement (Annual)